Schedule 13D ownership disclosure
Mirum Pharmaceuticals Inc
Security class unavailable · CUSIP: 604749101
Event date: 2022-08-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-222028
- Form type
- SC 13D
- Filer
- Frazier Life Sciences IX, L.P.
- CIK
- CIK 1720320
- Filed
- Aug 16, 2022
- Reporting period
- Aug 12, 2022
- Description
- Schedule 13D beneficial ownership